Delivery Process: Kenya Ghana and Pilot Vaccine

delivery process: Four successive doses must be administered on a strict timetable for it to work, according to The Japan Times. Trade-named Mosquirix, the drug has been developed by British pharmaceutical giant Glaxo Smith Kline in partnership with the PATH Malaria Vaccine Initiative. After more than three decades in development and almost 1 billion in investment, the cutting-edge trial will be rolled out in Malawi's capital Lilongwe this week and then in Kenya and Ghana next week. ; It aims to immunize 120,000 children aged 2 and under to assess the effectiveness of the pilot vaccine and whether the delivery process is feasible. It passed previous scientific testing including five years of clinical trials on 15,000 people in seven countries and was approved for the pilot program in 2015. Although the potential vaccine will not give full protection against the mosquito-borne disease, it is the furthest along in development and so far the most effective. Malaria episodes reduced by 40 percent in the trials. (news.financializer.com). As reported in the news.